July 2026

ENDOCRINOLOGY

CLINICAL IMPACT OF CGM IN NON-INSULIN TYPE 2 DIABETES

Featuring: ​​Grazia Aleppo, MD
Episode Summary​
​
Grazia Aleppo, MD, discusses the evolving role of continuous glucose monitoring (CGM) in non-insulin-treated Type 2 diabetes, drawing from her recent review published in Diabetes Technology and Therapeutics that examines evolving evidence and real‑world implications.
​
Practical considerations for integrating CGM into routine care are also reviewed, with an emphasis on early intervention and data-driven decision-making.
​
Key Topics
  • Evidence supporting CGM use in non-insulin-treated type 2 diabetes
  • Limitations of A1C and the role of time in range
  • Impact of CGM on patient engagement and self-management
  • Clinical and real-world outcomes associated with CGM adoption
  • Practical applications for endocrinology and primary care

​Read The Study
​Grazia Aleppo, MD, is a professor of Endocrinology and associate chief for Clinical Affairs in the Division of Endocrinology at Northwestern Medicine, where she also serves as medical director of the Diabetes Education and Training Program.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​

You May Also Like